Is Merck Stuck in the Slow Lane?
Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares retreated in early trading.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 72
What to Expect When Merck Reports Before the Opening Bell
Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year growth on the top and bottom lines.
Insmed’s Bronchiectasis Study Is a Breath of Fresh Air for Investors
Insmed is one of the few biotechs not tied to the coronavirus that is making a big move to start out the week. Essentially, the firm reported midstage study results for patients with non-cystic…
Is the Coronavirus the Kick-Start Gilead Sciences Stock Needs?
Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an effective treatment for the coronavirus.
FDA Approves First-Ever Peanut Allergy Treatment
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
Biotech Stocks Seeing the Biggest Boost From Coronavirus Outbreak
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Coronavirus Infections Climb Hand in Hand With These Biotech Stocks
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
Why Madrigal Pharma Stock Could Still Double From NASH Development
A positive research call indicates that Madrigal Pharmaceuticals shares could deliver more than 100% upside to investors over the coming year or so.
OpGen Takes a Different Approach to the Coronavirus
OpGen shares jumped on Thursday after the company announced that it will be joining the fight against the latest coronavirus outbreak.
Annovis Bio Enters the Market With a Bang
Clinical-stage, drug platform company Annovis Bio entered the market with a bang on Wednesday.
Will Teva Stock Collapse Before It Fixes Its Problems?
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of a turn…
How Far Will Pfizer Stock Slump?
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Short Sellers Can’t Make Up Their Mind on Big Pharma
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Why Biogen Could Become the King of Alzheimer’s Disease Treatment
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to treat…